RecruitingNCT06693622

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests: A Discrete Choice-Based Conjoint Analysis


Sponsor

University of Colorado, Denver

Enrollment

556 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria3

  • Provision to sign and date the consent form.
  • Stated willingness to comply with all study procedures and be available for the duration of the study.
  • Individual has 3 or more established risk factors for BE (age \> 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE/EAC).

Exclusion Criteria5

  • Unable to consent.
  • Prior diagnosis of BE/EAC.
  • Life limiting comorbidity/ disability.
  • Active dementia/ cognitive impairment.
  • Incarcerated.

Interventions

BEHAVIORALPatient survey

To assess patient preferences and barriers for attributes of BE/EAC screening modalities patients will complete a survey evaluating 5 domains: benefit of detection (sensitivity), convenience (time, setting), screening related physical harms (procedural discomfort), and financial harms. Prior to distribution, the survey will be refined and pretested among a sample of 5 patients.


Locations(1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06693622


Related Trials